Surge

About:

Surge personalizes the care of patients undergoing surgery by providing an accurate prediction of postoperative infections.

Website: https://www.surge.care

Twitter/X: Surge2Surgery

Top Investors: Eurazeo, Bpifrance, HCVC, 50 Partners, Kima Ventures

Description:

Surge is an immunological model capable of predicting postoperative infections. The company combines a single-cell assessment of the immune system before surgery with clinical data using a proprietary machine-learning algorithm. By analyzing the millions of immune cells in a small amount of blood, the platform can mimic surgical trauma in a test tube before surgery.